Top compounds associated with response to NOTO


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.004
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.11 0.004
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.093 0.004
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.091 0.005
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.006
mRNA ouabain CTRPv2 pan-cancer AAC 0.096 0.006
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.006
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.007
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.098 0.007
Download CSV